Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 18 Source: Estimated
- €514.4 million turnover
- 400 employees
-
31st Dec 17 Source: Estimated
- €321.6 million turnover
- 300 employees
- 4 more years available »
Ranking
By Turnover
(€514.4 million)- 150th in Top Companies
- 22nd in Health
- 20th in Pharma
By Employees
(400)- 403rd in Top Companies
- 64th in Health
- 41st in Pharma
- 400
- €514.4 million
Employees
- Shane Doyle Senior vice president
Latest News
- 5:48pm Facebook signals softer stance on ad rules for EU elections
- 4:50pm The sadness felt when your best friend at the office leaves
- 4:50pm The sadness you feel when your best friend at the office leaves
- 4:11pm Millions of people in the UK expect accounts to be hacked
- 3:57pm Tesla gets temporary order against man it claims was stalking its factory